ClinicalTrials.gg
CompletedNCT00171652Updated Oct 11, 2006

Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis

A Phase 3 interventional study of Diclofenac sodium gel 1% in Osteoarthritis, sponsored by Novartis. Completed at 48 sites in 2 countries. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2006-10-11.

Sponsored by Novartis · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
360
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 26 studies in Osteoarthritis by Novartis — none open to participants now, none under way, none of them phase 3. Osteoarthritis · Novartis.

Enrollment
11th of 26
360 · median 320
Started
2005
with 2 others
Phase 3
13 of 26
none open now
Registered
4th of 26
by date

Among the 26 studies in Osteoarthritis by Novartis, this one is the 11th largest by enrollment, is one of 3 that started in 2005, is one of 13 in phase 3, and was the 4th registered.

Osteoarthritis

2,977 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

None of the 26 studies in Osteoarthritis by Novartis is open now. The open studies under Osteoarthritis, anywhere →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 157 (55%) set no upper age limit and 71 (25%) stop at 75 or younger; 22 take children under 18; 30 take healthy volunteers.

This study: 40 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 26 studies in Osteoarthritis by Novartis as a file.
02

Study summary

This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of hand osteoarthritis.

03

Conditions studied

  • Osteoarthritis

Browse trials for

Keywords

  • Hand osteoarthritis, Topical NSAID, Diclofenac sodium
04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Key Inclusion criteria:

  • Osteoarthritis of the hand

Key Exclusion Criteria:

  • Other rheumatic disease, such as rheumatoid arthritis
  • Active gastrointestinal ulcer during the last year
  • Known allergy to analgesic drugs
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double
Enrollment
360 participants

Interventions

06

What researchers measure

Primary outcomes

  1. OA pain intensity in target hand at Week 4 and 6

  2. Total AUSCAN score in target hand at Week 4 and 6

  3. Global rating of disease activity by patient at Week 4 and 6

Secondary outcomes

  1. OA pain intensity and total AUSCAN score in target hand, and global rating of disease activity by patient at Weeks 1, 2 and 8

  2. AUSCAN pain, stiffness and physical function scores in target hand, and global rating of benefit by patient at Weeks 1, 2, 4, 6 and 8

  3. OA pain intensity in target hand and use of rescue medication recorded in diary

  4. Global evaluation of treatment at final visit

  5. Treatment responder rate according to OARSI criteria

07

Study locations

48 sites
  • Cergy, 95000, France
  • Clamart, 92140, France
  • Cournonterral, 34660, France
  • Fellering, 68470, France
  • Goussonville, 78930, France
  • Linas, 91310, France
  • Longpont sur Orge, 91310, France
  • Meaux, 77100, France
  • Nantes, 44000, France
  • Orly, 94310, France
  • Paris, 75010, France
  • Paris, 75011, France
  • Paris, 75015, France
  • Paris, 75020, France
  • Savigny sur Orge, 91600, France
  • Thouars, 79100, France
  • Villeneuve le Roi, 94290, France
  • Bad Hersfeld, 36251, Germany
  • Bad Nauheim, 61231, Germany
  • Berlin, 10589, Germany
  • Berlin, 10711, Germany
  • Berlin, 10961, Germany
  • Berlin, 12247, Germany
  • Berlin, 13125, Germany
  • Berlin, 13581, Germany
  • Berlin, 14163, Germany
  • Bochum, 44789, Germany
  • Dinslaken, 46535, Germany
  • Dortmund, 44263, Germany
  • Dreieich, 63303, Germany
  • Dresden, 01129, Germany
  • Frankfurt a/M, 60433, Germany
  • Hagen, 58099, Germany
  • Hamburg, 20249, Germany
  • Hamburg, 20357, Germany
  • Hamburg, 22143, Germany
  • Hamburg, 22767, Germany
  • Karlsruhe, 76133, Germany
  • Kassel, 34123, Germany
  • Leipzig, 04109, Germany
  • Ludwigshafen, 67069, Germany
  • München, 80333, Germany
  • München, 80339, Germany
  • München, 80538, Germany
  • München, 80798, Germany
  • Neustadt/Aisch, 91413, Germany
  • Nürnberg, 90441, Germany
  • Stuttgart, 70178, Germany
08

References and documents

Publications

  • Barthel HR, Peniston JH, Clark MB, Gold MS, Altman RD. Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis. Arthritis Res Ther. 2010;12(1):R7. doi: 10.1186/ar2906. Epub 2010 Jan 11. PubMed 20064249 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 2005 and a completion of Oct 2005. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2005
First posted
Sep 15, 2005
Start
May 2005
Completion
Oct 2005
Last update
Oct 11, 2006
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
No changes since tracking began. The registry record was last updated on Oct 11, 2006, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00171652
Lead sponsor
Novartis
First posted
Sep 15, 2005
Start date
May 2005
Completion
Oct 2005
Last update
Oct 11, 2006
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2006. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Diclofenac Sodium Gel

Start the discussion